Acorda Therapeutics, Inc.

Ownership Transactions Reported by 14 Insiders

Symbol
ACORQ on OTC
Location
Two Blue Hill Plaza, Pearl River, NY

There are no Buy or Sell transactions made by insiders since 11/5/2023

Acorda Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Ron Cohen President and CEO, Director $97.3K Mar 31, 2023
Lauren M. Sabella Chief Operating Officer $6.96K Sep 3, 2022
Robert Morales Interim PAO & PFO $2.88K Sep 3, 2021
Kerry M. Clem Chief Commercial Officer Mar 31, 2023
Peder Jensen Director Jun 22, 2023
John P. Kelley Director Jun 22, 2023
Neil S. Belloff General Counsel and Corp Secy Mar 31, 2023
Thomas M. Burns Director Jun 22, 2023
Sandra Panem Phd Director Jun 22, 2023
John Varian Director Jun 22, 2023
Catherine D. Strader Director Jun 2, 2021
Lorin Randall Director Jun 10, 2022
Michael A. Gesser Chief Financial Officer Nov 8, 2021
Greene Barry E Director Jun 2, 2021

Recent Insider Transactions by Companies or Individuals for Acorda Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.